← All stocks

Kalaris Therapeutics, Inc.

KLRS No buying or selling
CIK 0001754068 #4344 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Brainard Diana
Chief Executive Officer
723,363
$3.49M
−4.1%
Ferrara Napoleone
Director
504,000
$2.43M
Miller Edward
General Counsel
352,865
$1.70M
−1.4%
PATEL SAMIR CHANDRAKANT
Director
352,800
$1.70M
Sinha Vikas
See Remarks
49,129
$237.29K
−22.3%
AKKARAJU SRINIVAS
Director
19,408
$93.74K
Feinsod Matthew
Chief Medical Officer
4,030
$19.46K
Hagen Brett R
Chief Accounting Officer
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 22.9 over the window, from 5,043,357 to 115,536,550 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 31 Jul 2020